-
Vaccines, Blood & Biologics
-
Resources for You
-
-
Vaccines Research
-
Bacterial Polysaccharides
- Characterization of Vaccines Targeting Surface Carbohydrates in Bacterial Disease and Associated Manufacturing and Product Testing Issues
Wille Vann, PhD - Development and Standardization of Serological Criteria for Evaluation of New Vaccines
Milan Blake, PhD - Mass Spectrometry of Carbohydrates as a Tool for Characterization of Bacterial Vaccines and Pathogens
John F. Cipollo - Evaluation of Biomarkers 0f Bacterial Polysaccharide Vaccine Efficacy: The Innate Immune Response
Mustafa Akkoyunlu, MD, PhD - Improvement of Biological Product Quality by Application of New Technologies to Characterize of Vaccines and Blood Products: NMR Spectroscopy and Light Scattering
Daron Freedberg, PhD
-
-
Enteric & Sexually Transmitted Diseases
-
-
Mycobacterial Diseases & Cellular Immunology
-
-
Respiratory & Special Pathogens
- Improving Vaccine Manufacturing Evaluation for Bacterial Respiratory Pathogens
Drusilla Burns, PhD - Development and Evaluation of Pre-Clinical Safety and Efficacy Disease Models for Bacterial Vaccines: Anthrax and Pertussis (Whooping Cough)
Todd Merkel, PhD - Plague Vaccine Efficacy: Development of New Assays to Better Assess Vaccine Efficacy
Karen Meysick, PhD - Biomarkers of Vaccine Safety and Efficacy for Diphtheria Vaccines
Michael Schmitt, PhD - Developing Test Methods to Measure the Potency of Vaccine(s) and Antitoxin(s) against Botulism and Tetanus
James Keller, PhD
-
-
DNA & Hepatitus Viruses
- Development of Assays of Defined Sensitivity for the Regulatory Management of Novel Cell Substrates
Andrew Lewis, MD - DNA Virus Vaccines and Vectors
Jerry Weir, PhD - DNA Virus Vaccine Safety Issues: Contamination and Viral Latency
Philip Krause, MD - Hepatitis C vaccines: Development of in vitro and in vivo Systems for HCV Replication and Evaluation of Vaccine Efficacy
Stephen Feinstone, MD - Studies of Efficacy, Safety and Potency Assay Development for Prophylactic and Therapeutic Vaccines against Hepatitis Viruses
Marian Major, PhD
-
-
Methods Development
- Evaluation of Safety and Potency of Viral Vaccines Based on Analysis of Molecular Consistency
Konstantin M. Chumakov, PhD - New Molecular Approaches for Advanced Safety and Purity Testing of Vaccines
Vladimir Chizhikov, PhD - Establishment of Markers of Viral Vaccine Safety and Efficacy
Steven Rubin, MD
-
-
Pediatric & Respiratory Viral Diseases
- Facilitating Influenza Virus Vaccine Production by Optimizing Vaccine Strains
Zhiping Ye, MD, PhD - Developing Tests to Detect Biomarkers of Vaccine Efficacy to Respiratory Viruses that Infect Infants, Children and the Elderly
Judy Beeler, MD - Influenza Pathogenesis and Immunity
Maryna Eichelberger, PhD
-
-
Retrovirus Research
- HIV Influenza And Smallpox Vaccines: Development of New Assays and Animal Models for Evaluation of Vaccine Safety and Efficacy
Hana Golding, PhD - Biological Product Safety: Development Of Sensitive Assays for Detection of Latent Viruses in Vaccine Cell Substrates and Risk Assessment of Human Infection with Agents of Potential Concern in Biologics
Arifa Khan, PhD - Development of Quantitative Assays to Evaluate the Safety of Cell Substrates and Vaccines
Keith Peden, PhD
-
-
Vector Borne Viral Diseases
-
-
Immunology
-
Contact Us
Consumer Affairs Branch (CBER)
- (800) 835-4709
- (301) 827-1800
- ocod@fda.hhs.gov
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448
-
-
-